Intratumoral microvessel density and expression of ED-A/ED-B sequences of fibronectin in breast carcinoma Journal Article published Jun 1998 in European Journal of Cancer volume 34 issue 7 on pages 1081 to 1085 |
Is there consensus in the definition of endpoints in metastatic breast cancer?. Journal Article published 15 Jan 2009 in Cancer Research volume 69 issue 2 Supplement on page 3102 |
Survival analisis in breast cancer's women in Santa Catarina, Brazil. Journal Article published 15 Jan 2009 in Cancer Research volume 69 issue 2 Supplement on page 6093 |
Potential economic impact of the 21-gene recurrence score in Brazil. Journal Article published 15 Jan 2009 in Cancer Research volume 69 issue 2 Supplement on page 6102 |
Breast cancer brain metastases: evidence for neuronal-like adaptation in a ‘breast-to-brain’ transition? Journal Article published 6 May 2014 in Breast Cancer Research volume 16 issue 3 |
Genetics and Latinos: Proceedings of a National Summit Journal Article published 15 Apr 2005 in Cancer Research volume 65 issue 8 on pages 2996 to 2996 |
Abstract ES5-1: Place as a cause of breast cancer disparities in Appalachia Journal Article published 14 Feb 2018 in Cancer Research volume 78 issue 4 Supplement on pages ES5-1 to ES5-1 |
Breast cancer research and the European Union Clinical Trials Directive Journal Article published 20 Apr 2004 in Breast Cancer Research volume 6 issue 4 |
The future of breast radiography: European perspective Journal Article published Jul 2008 in Breast Cancer Research volume 10 issue S3 |
Arterial endothelium (ED) damage caused by 5-fluorouracil (5-FU) infusion may responsible for angina of colorectal cancer patients — animal model study Journal Article published Jan 1994 in European Journal of Cancer volume 30 on page S29 |
6606 POSTER Three drug regimen in SCLC-ED patients: a phase II study Journal Article published Sep 2007 in European Journal of Cancer Supplements volume 5 issue 4 on page 390 |
P76 Clinical experiences with therapeutic derivatives of the anti-ED-B fibronectin immunoprotein L19 Journal Article published Nov 2007 in European Journal of Cancer Supplements volume 5 issue 8 on page 33 |
Cisplatin — Paclitaxel — Topotecan (CPT) weekly administration in chemo-naive or pretreated extensive disease small cell lung cancer (ED-SCLC). A SICOG Phase II study Journal Article published Sep 1999 in European Journal of Cancer volume 35 on page S252 |
Myofibroblast and concurrent ED-B fibronectin phenotype in human stromal cells cultured from non-malignant and malignant breast tissue Journal Article published Jan 1994 in European Journal of Cancer volume 30 issue 1 on pages 66 to 73 |
A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimen Journal Article published Jan 1993 in European Journal of Cancer volume 29 issue 3 on pages 309 to 315 |
Stress response symptoms in adolescent and young adult children of parents diagnosed with cancer Journal Article published Jan 2005 in European Journal of Cancer volume 41 issue 2 on pages 288 to 295 |
9124 Phase I trial of sagopilone in combination with cisplatin as 1st-line therapy in patients with extensive-disease small-cell lung cancer (ED-SCLC) Journal Article published Sep 2009 in European Journal of Cancer Supplements volume 7 issue 2 on page 542 |
A phase III randomised trial testing accelerated chemotherapy with GM-CSF or cotrimoxazole in extensive-disease (ED) small-cell lung cancer (SCLS). A study by the European Lung Cancer Working Party Journal Article published Apr 2001 in European Journal of Cancer volume 37 on page S30 |
Abstract 4705: Therapeutic activity of bivalent BRD4 inhibitor AZD5153 in hematological cancers Journal Article published 15 Jul 2016 in Cancer Research volume 76 issue 14 Supplement on pages 4705 to 4705 |
Final Results of ABCSG-24, a Randomized Phase III Study Comparing Epirubicin, Docetaxel, and Capecitabine (EDC) to Epirubicin and Docetaxel (ED) as Neoadjuvant Treatment for Early Breast Cancer and Comparing ED/EDC + Trastuzumab (T) to ED/EDC as Neoadjuvant Treatment for Early HER-2 Positive Breast Cancer. Journal Article published 15 Dec 2009 in Cancer Research volume 69 issue 24 Supplement on pages 1081 to 1081 |